Genomic Medicine across the world; challenges, progress, opportunities and patient impact.
I will present briefly the view of genomic medicine journey, making analogies with other technologies absorbed into healthcare, such as intra-vital imaging in the 19th Century. I will share my experience and observations as a researcher involved in technology transfer of genomics to healthcare across many locations worldwide, highlighting the challenges, the progress, the opportunities and the patient impact of genomic medicine.
Ewan Birney is Deputy Director General of EMBL. He is also Director of EMBL-EBI with Dr Rolf Apweiler, and runs a small research group. Ewan completed his PhD at the Wellcome Sanger Institute with Richard Durbin. In 2000, he became Head of Nucleotide data at EMBL-EBI and in 2012 he took on the role of Associate Director at the institute. He became Director of EMBL-EBI in 2015. In 2020, Ewan became the Deputy Director General of EMBL. In this role, he assists the EMBL Director General in relation to engagement with EMBL Member States and external representation.